In studies comparing chemotherapy plus<unk> , dexamethasone and a 5-HT3 antagonist to chemotherapy plus placebo, dexamethasone and a 5-HT3 antagonist, most side effects had comparable frequencies in both groups, and differed more between chemotherapy regimens than between<unk>  and placebo groups. Common side effects included decreased appetite (9% under<unk>  vs. 7% under placebo), neutropenia (9% vs. 8% or 7% vs. 6%, depending on the kind of chemotherapy), dizziness (6% vs. 4%), indigestion and stomatitis (both 4% vs. 2%).
Rolapitant
Ezlopitant
Terguride
Telmisartan
Isosorbide dinitrate
Mitapivat
Cobicistat
Eluxadoline